BRIEF published on 09/26/2024 at 12:35, 8 days 18 hours ago SCHOTT Pharma, Gerresheimer et le groupe Stevanato forment une « alliance pour la RTU » Efficacité Pharmaceutique Confinement Des Drogues Alliance RTU Risque Opérationnel Emballage Stérile
BRIEF published on 09/26/2024 at 12:35, 8 days 18 hours ago SCHOTT Pharma, Gerresheimer, and Stevanato Group Form “Alliance for RTU” Drug Containment Pharmaceutical Efficiency RTU Alliance Operational Risk Sterile Packaging
PRESS RELEASE published on 09/26/2024 at 12:30, 8 days 18 hours ago SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU” SCHOTT Pharma, Gerresheimer, and Stevanato Group form Alliance for RTU, advancing ready-to-use containers for pharmaceutical manufacturing efficiency and patient safety SCHOTT Pharma Gerresheimer Pharmaceutical Manufacturing Stevanato Group Alliance For RTU
BRIEF published on 09/05/2024 at 07:05, 1 month ago SCHOTT Pharma cotée au MDAX pour la première fois Bourse De Francfort Objectifs De Croissance Confiance Du Marché Inclusion MDAX Confinement Des Drogues
BRIEF published on 09/05/2024 at 07:05, 1 month ago SCHOTT Pharma Listed on MDAX for the First Time Frankfurt Stock Exchange Growth Targets Market Confidence MDAX Inclusion Drug Containment
PRESS RELEASE published on 09/05/2024 at 07:00, 1 month ago Promotion for SCHOTT Pharma: Listed on the MDAX for the first time SCHOTT Pharma AG & Co. KGaA to be included in the MDAX index, marking a significant milestone. Company continues to expand and strengthen market position Market Position SCHOTT Pharma Growth Targets MDAX Share Listing
BRIEF published on 08/29/2024 at 07:05, 1 month 7 days ago SCHOTT Pharma Delivers Strong Third Quarter Results and Raises FY 2024 Revenue Guidance Innovation Revenue Growth EBITDA Margin High-value Solutions Expansion Projects
BRIEF published on 08/29/2024 at 07:05, 1 month 7 days ago SCHOTT Pharma publie de solides résultats au troisième trimestre et relève ses prévisions de chiffre d'affaires pour l'exercice 2024 Innovation Croissance Des Revenus Marge D'EBITDA Des Solutions À Forte Valeur Ajoutée Projets D'agrandissement
PRESS RELEASE published on 08/29/2024 at 07:00, 1 month 7 days ago SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance SCHOTT Pharma reports strong Q3 results with 21% revenue growth, EBITDA margin of 28.2%, and raises FY 2024 revenue guidance. Strategic focus on innovation and growth projects Innovation Revenue Growth FY 2024 Guidance SCHOTT Pharma Q3 Results
BRIEF published on 08/08/2024 at 16:25, 1 month 27 days ago SCHOTT Pharma Aligns Climate Actions with Paris Agreement Goals Decarbonization Climate Action Green Electricity GHG Emissions Paris Agreement
Published on 10/05/2024 at 04:00, 3 hours 29 minutes ago Agents Amazed by Incredible New Benefits Announced at Epique Realty Livestream Event
Published on 10/05/2024 at 03:30, 3 hours 59 minutes ago Agents Excited by Transformative Company Announcements at Epique Realty Livestream Event
Published on 10/05/2024 at 00:05, 7 hours 24 minutes ago WOGC Enters Into Letter of Intent to Acquire Terra Metals Inc.
Published on 10/04/2024 at 20:45, 10 hours 44 minutes ago ONAR Appoints Sara Wetmore to Lead Corporate Communications and Marketing
Published on 10/04/2024 at 19:00, 12 hours 29 minutes ago Clear Start Tax's Proven Approach to Resolving Client's Tax Debt
Published on 10/04/2024 at 18:33, 12 hours 55 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 10/04/2024 at 18:15, 13 hours 14 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 10/04/2024 at 17:20, 14 hours 9 minutes ago The subscription price for exercise of warrants series TO5 has been determined to SEK 0.40
Published on 10/04/2024 at 16:55, 14 hours 34 minutes ago World Green Economy Summit 2024 Hosts a High-Level Ministerial Roundtable
Published on 10/04/2024 at 18:30, 12 hours 59 minutes ago ALTAREIT : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES SEPTEMBRE 2024
Published on 10/04/2024 at 18:30, 12 hours 59 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/04/2024 at 18:30, 12 hours 59 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 10/04/2024 at 18:30, 12 hours 59 minutes ago ALTAREA : DECLARATION MENSUELLE DES OPERATIONS REALISEES PAR LA SOCIETE SUR SES PROPRES TITRES SEPTEMBRE 2024
Published on 10/04/2024 at 18:27, 13 hours 2 minutes ago Total number of voting rights and shares making up the share capital at September 30, 2024
